Showing 1 - 7 results of 7 for search 'David A Norris', query time: 3.18s Refine Results
  1. 1
    CPP‐E1A fusion peptides inhibit CtBP‐mediated transcriptional repression

    CPP‐E1A fusion peptides inhibit CtBP‐mediated transcriptional repression by Melanie A. Blevins, Caiguo Zhang, Lingdi Zhang, Hong Li, Xueni Li, David A. Norris, Mingxia Huang, Rui Zhao

    Published 2018-08-01
    Get full text
    Article
  2. 2
    Fast response temperature measurement and highly reproducible heating methods for 96-well plates

    Fast response temperature measurement and highly reproducible heating methods for 96-well plates by Yiqun G. Shellman, Deborah Ribble, Ming Yi, Theresa Pacheco, Mark Hensley, Dudley Finch, Frank Kreith, Roop L. Mahajan, David A. Norris

    Published 2004-06-01
    Get full text
    Article
  3. 3
    Transcriptome profiling of whole blood cells identifies PLEK2 and C1QB in human melanoma.

    Transcriptome profiling of whole blood cells identifies PLEK2 and C1QB in human melanoma. by Yuchun Luo, Steven Robinson, Junichi Fujita, Lisa Siconolfi, Jay Magidson, Carl K Edwards, Karl Wassmann, Kathleen Storm, David A Norris, Danute Bankaitis-Davis, William A Robinson, Mayumi Fujita

    Published 2011-01-01
    Get full text
    Article
  4. 4
    Combined anti-tumor necrosis factor-α therapy and DMARD therapy in rheumatoid arthritis patients reduces inflammatory gene expression in whole blood compared to DMARD therapy alone

    Combined anti-tumor necrosis factor-α therapy and DMARD therapy in rheumatoid arthritis patients reduces inflammatory gene expression in whole blood compared to DMARD therapy alone... by Carl K Edwards, Carl K Edwards, Julie Schwartz Green, Hans-Dieter eVolk, Michael eSchiff, Brian eKotzin, Hiroaki eMitsuya, Tatsuya eKawaguchi, Ken-Mei eSakata, John eCheronis, David eTrollinger, Danute eBankaitis-Davis, Charles A Dinarello, David A Norris, David A Norris, Michael P Bevilacqua, Mayumi eFujita, Mayumi eFujita, Gerd-Rudiger eBermester

    Published 2012-12-01
    Get full text
    Article
  5. 5
    A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and Azacitidine

    A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and Azacitidine by Chiara R. Dart, Nabanita Mukherjee, Carol M. Amato, Anabel Goulding, Morgan MacBeth, Robert Van Gulick, Kasey L. Couts, James R. Lambert, David A. Norris, William A. Robinson, Yiqun G. Shellman

    Published 2021-07-01
    Get full text
    Article
  6. 6
    MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockade

    MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockade by Nabanita Mukherjee, Elizabeth Katsnelson, Tonya M. Brunetti, Kylie Michel, Kasey L. Couts, Karoline A. Lambert, William A. Robinson, Martin D. McCarter, David A. Norris, Richard P. Tobin, Yiqun G. Shellman

    Published 2024-03-01
    Get full text
    Article
  7. 7
    JAK inhibition decreases the autoimmune burden in Down syndrome

    JAK inhibition decreases the autoimmune burden in Down syndrome by Angela L Rachubinski, Elizabeth Wallace, Emily Gurnee, Belinda A Enriquez-Estrada, Kayleigh R Worek, Keith P Smith, Paula Araya, Katherine A Waugh, Ross E Granrath, Eleanor Britton, Hannah R Lyford, Micah G Donovan, Neetha Paul Eduthan, Amanda A Hill, Barry Martin, Kelly D Sullivan, Lina Patel, Deborah J Fidler, Matthew D Galbraith, Cory A Dunnick, David A Norris, Joaquín M Espinosa

    Published 2024-12-01
    Get full text
    Article

Search Tools: